Skip to main content
SpringerLink
Log in

Sustainability of a well-monitored salt iodization program in Iran: Marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective: Two yr after legislation of salt iodization of 40 parts per million (ppm) in 1994, goiter was still endemic and urinary iodine concentration (UIC) remained elevated in many provinces of Iran. Goiter prevalence and UIC were compared 2 and 7 yr after sustained consumption of uniformly iodized salt by Iranian households. Methods: Schoolchildren (7–10 yr) of all provinces were randomly selected by cluster sampling from December 2000 to June 2001. Goiter rate, UIC, and household salt iodine values were compared to those in 1996. Factory salt iodine was also compared in 2001 vs 1996. Ultrasonographically determined thyroid volumes of 7–10 yr old children were compared in 2001 vs 1999. Results: In 2001 (no.=33600) vs 1996 (no.=36178), total, grade 1, and grade 2 goiter rates were 13.9 vs 53.8%, 11.0 vs 44.8%, and 2.9 vs 9.0%, respectively (p<0.0001). Weighted total goiter rate was 9.8% in 2001. Median (range) UIC in 2001 (no.=3329) was 165 (18–499) μg/l and in 1996 (no.=2917) was 205 (10–2300) μg/l (p<0.0001). In 2001 vs 1996, mean±SD for iodine salt content was 32.7±10.1 vs 33.0±10.2 ppm (p=0.68) in households and was 33.2±13.4 and 33.8±13.2 ppm (p=0.57) in factories, respectively. Among 7–10 yr old children in 2001 (no.=400) vs 1999 (no.=396), only 7-yr-old children in 2001 (the only group with probably no history of iodine deficiency) showed significant smaller thyroid volumes by ultrasonography compared to those in 1999. Conclusions: After 7 yr of optimized iodized-salt supplementation in Iran, adequate UIC values and marked reduction in goiter rate have been achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Delange FM, Dunn JT. Iodine deficiency. In: Braverman LE, Utiger RD eds. Werner & Ingbar’s The Thyroid: A fundamental and clinical text. 9th ed. Philadelphia: Lippincott Williams & Wilkins 2005, 264–88.

    Google Scholar 

  2. Hetzel BS. Eliminating iodine deficiency disorders-the role of the International Council in the global partnership. Bull World Health Organ 2002, 80: 410–3.

    PubMed Central  PubMed  Google Scholar 

  3. Delange F. Iodine deficiency as a cause of brain damage. Postgrad Med J 2001, 77: 217–20.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Delange F, de Benoist B, Pretell E, Dunn JT. Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 2001, 11: 437–47.

    Article  PubMed  CAS  Google Scholar 

  5. Vitti P, Delange F, Pinchera A, Zimmermann M, Dunn JT. Europe is iodine deficient. Lancet 2003, 361: 1226.

    Article  PubMed  Google Scholar 

  6. Dunn JT. What’s happening to our iodine? J Clin Endocrinol Metab 1998, 83: 3398–400.

    PubMed  CAS  Google Scholar 

  7. WHO, UNICEF, and ICCIDD. Progress towards the elimination of iodine deficiency disorders (IDD). Geneva: WHO publ. WHO/NHD/99.4. 1999, 1–33.

    Google Scholar 

  8. WHO/UNICEF/ICCIDD. Assessment of the iodine deficiency disorders and monitoring their elimination. A guide for programme managers. 2nd ed. Geneva: WHO publ. WHO/NHD/01.1. 2001, 1–107.

    Google Scholar 

  9. de Benoist B, Andersson M, Takkouche B, Egli I. Prevalence of iodine deficiency worldwide. Lancet 2003, 362: 1859–60.

    Article  PubMed  Google Scholar 

  10. Dunn JT. Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J Clin Endocrinol Metab 1996, 81: 1332–5.

    PubMed  CAS  Google Scholar 

  11. Zimmermann MB, Wegmüller R, Zeder C, Torresani T, Chaouki N. Rapid relapse of thyroid dysfunction and goiter in school-age children after discontinuation of salt iodization. Am J Clin Nutr 2004, 79: 642–5.

    PubMed  CAS  Google Scholar 

  12. Guttikonda K, Burgess JR, Hynes K, Boyages S, Byth K, Parameswaran V. Recurrent iodine deficiency in Tasmania, Australia: a salutary lesson in sustainable iodine prophylaxis and its monitoring. J Clin Endocrinol Metab 2002, 87: 2809–15.

    Article  PubMed  CAS  Google Scholar 

  13. Emami A, Shahbazi H, Sabzevari M, et al. Goiter in Iran. Am J Clin Nutr 1969, 22: 1584–8.

    PubMed  CAS  Google Scholar 

  14. Azizi F, Kimiagar M, Nafarabadi M, Yassai M. Current status of iodine deficiency in the Islamic Republic of Iran. EMR Health Serv J 1990, 8: 23–7.

    Google Scholar 

  15. Azizi F, Sheikholeslam R, Hedayati M, et al. Sustainable control of iodine deficiency in Iran: beneficial results of the implementation of the mandatory law on salt iodization. J Endocrinol Invest 2002, 25: 409–13.

    Article  PubMed  CAS  Google Scholar 

  16. Azizi F, Delshad H, Mehrabi Y. Thyroid volumes in schoolchildren of Tehran: comparison with European schoolchildren. J Endocrinol Invest 2001, 24: 756–62.

    Article  PubMed  CAS  Google Scholar 

  17. Zimmermann MB, Hess SY, Adou P, Toresanni T, Wegmüller R, Hurrell RF. Thyroid size and goiter prevalence after introduction of iodized salt: a 5-y prospective study in schoolchildren in Côte d’Ivoire. Am J Clin Nutr 2003, 77: 663–7.

    PubMed  CAS  Google Scholar 

  18. Delange F. What do we call a goiter? Eur J Endocrinol 1999, 140: 486–8.

    Article  PubMed  CAS  Google Scholar 

  19. Lemeshow S, Hosmer DW Jr, Klar J, Lwanga SK. Adequacy of sample size in health studies. 1st ed. Chichester: John Wiley & Sons, 1990.

    Google Scholar 

  20. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. 3rd ed. New York: John Wiley & Sons, 1999.

    Google Scholar 

  21. Levy PS. Cluster sampling. In: Armitage PA, Colton TD eds. Encyclopedia of biostatistics. New York: Wiley, 1998.

    Google Scholar 

  22. Tonglet R, Bourdoux P, Dramaix M, Hennart P, Ermans A. Interobserver variation in the assessment of thyroid enlargement: a pitfall in surveys of the prevalence of endemic goiter. Food Nutr Bull 1994, 15: 64–70.

    Google Scholar 

  23. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of thyroid lobes by real-time ultrasound (author’s transl). Dtsch Med Wochenschr 1981, 106: 1338–40.

    Article  PubMed  CAS  Google Scholar 

  24. Zimmermann MB, Molinari L, Spehl M, et al. Towards a consensus on reference values for thyroid volume in iodine-replete schoolchildren: results of a workshop on inter-observer and inter-equipment variation in sonographic measurement of thyroid volume. Eur J Endocrinol 2001, 144: 213–20.

    Article  PubMed  CAS  Google Scholar 

  25. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. Methods for measuring iodine in urine. Wagenigen, The Netherlands: ICCIDD. 1993, 1–71.

    Google Scholar 

  26. Narasinga Rao BS, Ranganathan S. A simple field kit for testing iodine in salt. Food Nutr Bull 1985, 7: 70–2.

    Google Scholar 

  27. De Maeyer EM, Lowestein FW, Thilly CH. The control of endemic goiter. Geneva: WHO, 1979.

    Google Scholar 

  28. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916, 17: 863–71.

    Article  Google Scholar 

  29. Zimmermann MB, Hess SY, Molinari L, et al. New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. Am J Clin Nutr 2004, 79: 231–7.

    PubMed  CAS  Google Scholar 

  30. Dumont JE, Ermans AM, Maenhaut C, Coppée F, Stanbury JB. Large goiter as a maladaptation to iodine deficiency. Clin Endocrinol 1995, 43: 1–10.

    Article  CAS  Google Scholar 

  31. Delange F. Adaptation to iodine deficiency during growth: etiopathogenesis of endemic goiter and cretinism. In: Delange F, Fisher D, Malvaux P eds. Pediatric thyroidology. Basel: Karger 1985, 295–396.

    Google Scholar 

  32. Jooste PL, Weight MJ, Lombard CJ. Short-term effectiveness of mandatory iodization of table salt, at an elevated iodine concentration, on the iodine and goiter status of schoolchildren with endemic goiter. Am J Clin Nutr 2000, 71: 75–80.

    PubMed  CAS  Google Scholar 

  33. Pardede LV, Hardjowasito W, Gross R, et al. Urinary iodine excretion is the most appropriate outcome indicator for iodine deficiency at field conditions at district level. J Nutr 1998, 128: 1122–6.

    PubMed  CAS  Google Scholar 

  34. Peterson S, Sanga A, Eklöf H, et al. Classification of thyroid size by palpation and ultrasonography in field surveys. Lancet 2000, 355: 106–10.

    Article  PubMed  CAS  Google Scholar 

  35. Aydin K, Kendirci M, Kurtoglu S, Karakucuk EI, Kiris A. Iodine and selenium deficiency in school-children in an endemic goiter area in Turkey. J Pediatr Endocrinol Metab 2002, 15: 1027–31.

    Article  PubMed  CAS  Google Scholar 

  36. Köhrle J, Jakob F, Contempré B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005, 26: 944–84.

    Article  PubMed  CAS  Google Scholar 

  37. Zimmermann M, Adou P, Torresani T, Zeder C, Hurrell R. Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d’Ivoire. Am J Clin Nutr 2000, 71: 88–93.

    PubMed  CAS  Google Scholar 

  38. Hess SY, Zimmermann MB, Adou P, Torresani T, Hurrell RF. Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Cote d’Ivoire. Am J Clin Nutr 2002, 75: 743–8.

    PubMed  CAS  Google Scholar 

  39. Zimmermann MB, Wegmüller R, Zeder C, Chaouki N, Torresani T. The effects of vitamin A deficiency and vitamin A supplementation on thyroid function in goitrous children. J Clin Endocrinol Metab 2004, 89: 5441–7.

    Article  PubMed  CAS  Google Scholar 

  40. Santini F, Vitti P, Ceccarini G, et al. In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 2003, 26: 950–5.

    Article  PubMed  CAS  Google Scholar 

  41. Rossi M, Dimida A, Dell’Anno MT, et al. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. J Pharmacol Exp Ther 2007, 320: 465–74.

    Article  PubMed  CAS  Google Scholar 

  42. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 1998, 8: 827–56.

    Article  PubMed  CAS  Google Scholar 

  43. Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM. Environmental chemicals and thyroid function. Eur J Endocrinol 2006, 154: 599–611.

    Article  PubMed  CAS  Google Scholar 

  44. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998, 83: 765–9.

    Article  PubMed  CAS  Google Scholar 

  45. Mazziotti G, Premawardhana LD, Parkes AB, et al. Evolution of thyroid autoimmunity during iodine prophylaxis—the Sri Lankan experience. Eur J Endocrinol 2003, 149: 103–10.

    Article  PubMed  CAS  Google Scholar 

  46. Harach HR, Escalante DA, Day ES. Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Endocr Pathol 2002, 13: 175–81.

    Article  PubMed  Google Scholar 

  47. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998, 8: 83–100.

    Article  PubMed  CAS  Google Scholar 

  48. Zimmermann M, Delange F. Iodine supplementation of pregnant women in Europe: a review and recommendations. Eur J Clin Nutr 2004, 58: 979–84.

    Article  PubMed  CAS  Google Scholar 

  49. Azizi F, Hedayati M, Rahmani M, Sheikholeslam R, Allahverdian S, Salarkia N. Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005, 28: 23–9.

    Article  PubMed  CAS  Google Scholar 

  50. Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health and Nutrition Examination Survey 2001–2002. Thyroid 2005, 15: 692–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Research Center, Shaheed Beheshti University of Medical Sciences, Iran

    F. Azizi MD (Professor of Internal Medicine and Endocrinology, ICCIDD Coordinator for the Middle East & North Africa), L. Mehran, A. Ordookhani, M. Hedayati, M. Padyab & P. Mirmiran

  2. Nutrition Department, Ministry of Health and Medical Education, Tehran, IR Iran

    R. Sheikholeslam & M. Naghavi

Authors
  1. F. Azizi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Mehran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Sheikholeslam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Ordookhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Naghavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Hedayati
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Padyab
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Mirmiran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Azizi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azizi, F., Mehran, L., Sheikholeslam, R. et al. Sustainability of a well-monitored salt iodization program in Iran: Marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt. J Endocrinol Invest 31, 422–431 (2008). https://doi.org/10.1007/BF03346386

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346386

Key-words

Search

Navigation